CD8A and neoplasm: Tumor cells can induce T cell dysfunction through direct receptor-ligand interactions, expressing co-inhibitory ligands, such as programmed death-ligand 1 (PD-L1) to inhibit CD8+ tumor-infiltrating lymphocytes’ (TIL) function through programmed death-1 (PD-1), a process further enhanced through contact with the immune system [7].